PlainRecalls
FDA Drug Critical Class I Terminated

Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290

Reported: June 20, 2018 Initiated: May 24, 2018 #D-0875-2018

Product Description

Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290

Reason for Recall

Contraceptive Tablets Out of Sequence.

Details

Recalling Firm
Allergan, PLC.
Units Affected
168,768 blister cards (4,725,504 softgel capsules)
Distribution
US Nationwide
Location
Madison, NJ

Frequently Asked Questions

What product was recalled?
Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290. Recalled by Allergan, PLC.. Units affected: 168,768 blister cards (4,725,504 softgel capsules).
Why was this product recalled?
Contraceptive Tablets Out of Sequence.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 20, 2018. Severity: Critical. Recall number: D-0875-2018.